Physician profile
Kyle William Dammann
NPI 1487213666
$1,494.47
in general payments reported to CMS, 2019-2025
15 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $161 · 2021: $77.43 · 2022: $326 · 2023: $140 · 2024: $326 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $269.81 | 2021-2025 | Collagenase Santyl, Oasis, Stravix |
| Stryker Corporation | $230.97 | 2022 | |
| Csl Behring | $216.90 | 2019-2023 | Kcentra |
| Medtronic, INC. | $205.70 | 2022-2025 | Signia, Situate, Ligasure |
| Acell, INC. | $144.78 | 2019 | |
| Integra Lifesciences Corporation | $87.65 | 2020 | |
| Boston Scientific Corporation | $66.55 | 2022-2025 | Spyglass Discover |
| Tei Medical INC. | $63.86 | 2019 | |
| Kci USA, INC. | $54.92 | 2019-2020 | |
| Ethicon US, LLC | $48.20 | 2020-2022 | |
| Innovation Technologies INC | $23.98 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $23.50 | 2025 | Exparel |
| Allergan, INC. | $22.18 | 2021 | |
| Zimmer Biomet Holdings, INC. | $19.67 | 2019 | |
| W. L. Gore & Associates, INC. | $15.80 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Dammann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.